Minimize Uncertainty – Make Informed Decisions – Succeed

Women's_Health

Women’s Health Video Recap—February 18, 2026

February 18, 2026Bocunebart,Bone-Viva,migraine,menstrual blood test,BioPharma and Tech News,Canada.,Ovarian Cancer,cervical cancer,TNBC,Keytruda,Lupus,PPMS,Japan,Women's Health News,Fenebrutinib,DatrowaySaphnelo,Kisqali

This biweekly Women’s Health video recap  covers a range of developments,…

by LucidQuest

Immunology

Immunology Today—February 18, 2026

February 18, 2026roche,BioPharma and Tech News,Eli Lilly,Ulcerative Colitis,Crohns Disease,Immunology News,mirikizumab,chronic spontaneous urticaria,primary membranous nephropathy,obinutuzumabbarzolvolimab,golimumab biosimilar

This week's Immunology update summarizes key developments in clinical trials,…

by LucidQuest

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Danaher to acquire Masimo in $9.9bn all-cash deal

February 18, 2026market access,medtech,diagnostics,Lucid Diligence Brief,mergers and acquisitions,integration,patient monitoring,hospital contracting,antitrust,HSR,synergiesgovernance

Lucid Diligence Brief: Danaher to acquire Masimo in $9.9bn all-cash deal…

by Timos Papagatsias

Obesity Weekly News

Obesity Video Recap—February 17, 2026

February 17, 2026CagriSema,Shanghai Shiling Pharmaceutical,wegovy,Semaglutide Nasal Spray,merck,Chong Kun Dang,pfizer,Pacific Medical Industries,sanofi,Seglupac,Celltrion,Biocon,BioPharma and Tech News,Novo Nordisk,Ozempic,Keytruda,Viking Therapeutics,Obesity NewsDupixent,Samsung Bioepis

This biweekly Obesity video recap highlights major clinical readouts,…

by LucidQuest

Obesity Weekly News

Obesity Today—February 17, 2026

February 17, 2026semaglutide,astrazeneca,BioPharma and Tech News,obesity,Novo Nordisk,Tirzepatide,Viking Therapeutics,GLP-1 receptor agonist,oral GLP-1Obesity News,Generic obesity drugs

This week's Obesity update highlights late-stage clinical progress, Phase 3…

by LucidQuest

Endocrinology

Endocrinology Today—February 17, 2026

February 17, 2026semaglutide,BioPharma and Tech News,osteoporosis,type 2 diabetes,Insulin Resistance,GLP-1 receptor agonist,Denosumab,Endocrinology News,Continuous Glucose MonitoringAutomated insulin delivery,Diabetic foot ulcer

This week's Endocrinology update covers research-driven disease biology…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Moonwalk Biosciences pivots from CRISPR-based epigenetic editing to siRNA obesity therapies

February 17, 2026biotech,clinical trials,drug discovery,obesity,Lucid Diligence Brief,payer access,RNAi,siRNA,cardiometabolic,epigenetic editing,deliveryventure investing

Lucid Diligence Brief: Moonwalk Biosciences pivots from CRISPR-based epigenetic…

by Timos Papagatsias

Hematology

Hematology Today—February 16, 2026

February 16, 2026Senti Biosciences,Yatiri Bio,sanofi,ProteoCharts,Hemophilia A,Foghorn Therapeutics,BioPharma and Tech News,Gyala Therapeutics,Rilzabrutinib,Rondecabtagene Autoleucel,Lyell Immunopharma,Elicera Therapeutics,World Health Organization,Disc Medicine,Acute Myeloid Leukemia,Bitopertin,Hematology News,World Health Assembly,Chugai Pharmaceutical,Bleeding Disorders,Myelodysplastic syndromes,Large B-cell lymphoma,T-cell acute lymphoblastic leukemiaErythropoietic protoporphyria,warm autoimmune hemolytic anemia

This weekly Hematology update covers key developments  including late-stage…

by LucidQuest

Oncology News

Oncology Video Recap—February 16, 2026

February 16, 2026Kisqali,Zovegalisib,FDA,Zanzalintinib,breast cancer,KB707,BioPharma and Tech News,Ameluz,Colorectal Cancer,basal cell carcinoma,Ovarian Cancer,regulatory milestones,gastric cancer,MHLW Japan,CHMP,Keytruda,Imfinzi,Oncology News,Non-small cell lung cancer,DatrowayRMAT designation,Breakthrough Therapy designation

This biweekly Oncology video recap is covering key developments across the…

by LucidQuest

Onco_background

Oncology Today—February 16, 2026

February 16, 2026Datroway,Ameluz,merck,SOFIE Biosciences,BioPharma and Tech News,HanchorBio,Keytruda,Adlai Nortye,Innovent Biologics,Biofrontera,Krystal Biotech,Superficial Basal Cell Carcinoma,Daiichi Sankyo,Oncology News,Henlius,platinum-resistant ovarian cancer,Non-small cell lung cancer,Triple-negative breast cancer,REQORSAGenprex,Pancreatic ductal adenocarcinoma

This week's Oncology update covers regulatory actions, clinical trial progress,…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Genhouse Bio and Gilead in GH31 synthetic-lethal oncology $1.5B deal

February 16, 2026Oncology,clinical trials,market access,biopharma,Biomarkers,Lucid Diligence Brief,diligence,licensing deals,China biotech,synthetic lethality,MAT2AMTAP deletion

Lucid Diligence Brief: Genhouse Bio and Gilead in GH31 synthetic-lethal…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Disc Medicine bitopertin FDA CRL

February 15, 2026clinical trials,market access,FDA,hematology,dermatology,rare disease,Orphan Drugs,accelerated approval,Lucid Diligence Brief,diligencecompetitive landscape

Lucid Diligence Brief: Disc Medicine bitopertin FDA CRL Professional audiences…

by Timos Papagatsias

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.